AU2001269046A1 - Use of therapeutic benzamide derivatives - Google Patents
Use of therapeutic benzamide derivativesInfo
- Publication number
- AU2001269046A1 AU2001269046A1 AU2001269046A AU6904601A AU2001269046A1 AU 2001269046 A1 AU2001269046 A1 AU 2001269046A1 AU 2001269046 A AU2001269046 A AU 2001269046A AU 6904601 A AU6904601 A AU 6904601A AU 2001269046 A1 AU2001269046 A1 AU 2001269046A1
- Authority
- AU
- Australia
- Prior art keywords
- benzamide derivatives
- therapeutic
- therapeutic benzamide
- derivatives
- benzamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000003936 benzamides Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Furan Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0013378.5A GB0013378D0 (en) | 2000-06-01 | 2000-06-01 | Use of therapeutic benzamide derivatives |
GB0013378 | 2000-06-01 | ||
PCT/EP2001/006242 WO2001097810A2 (en) | 2000-06-01 | 2001-06-01 | Use of therapeutic benzamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001269046A1 true AU2001269046A1 (en) | 2002-01-02 |
Family
ID=9892822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001269046A Abandoned AU2001269046A1 (en) | 2000-06-01 | 2001-06-01 | Use of therapeutic benzamide derivatives |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040044008A1 (en) |
EP (1) | EP1286670A2 (en) |
JP (1) | JP2003535900A (en) |
AU (1) | AU2001269046A1 (en) |
GB (1) | GB0013378D0 (en) |
WO (1) | WO2001097810A2 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2390B1 (en) | 2001-04-06 | 2007-06-17 | شركة جانسين فارماسوتيكا ان. في | Lipid lowering biphenulcarboxamides |
MXPA03011707A (en) | 2001-06-28 | 2004-03-19 | Pfizer Prod Inc | Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion. |
GB0129013D0 (en) * | 2001-12-04 | 2002-01-23 | Glaxo Group Ltd | Compounds |
GB0129015D0 (en) * | 2001-12-04 | 2002-01-23 | Glaxo Group Ltd | Compounds |
ZA200502496B (en) | 2002-02-28 | 2005-10-12 | Japan Tobacco Inc | Ester compound and medicinal use thereof. |
UA79300C2 (en) | 2002-08-12 | 2007-06-11 | Janssen Pharmaceutica Nv | N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
EP1669345A4 (en) | 2003-08-29 | 2008-02-20 | Japan Tobacco Inc | Ester derivative and medicinal use thereof |
FI20031536A0 (en) | 2003-10-20 | 2003-10-20 | Biotie Therapies Oyj | High affinity ligands for influenza viruses and their production processes |
UA83510C2 (en) * | 2003-12-09 | 2008-07-25 | Янссен Фармацевтика Н.В. | N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b |
FR2871463B1 (en) * | 2004-06-11 | 2006-09-22 | Merck Sante Soc Par Actions Si | AROYL-O-PIPERIDINE-STRUCTURED DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THERAPEUTIC APPLICATIONS THEREOF |
BRPI0515500A (en) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | pyridazine derivatives for stearoyl coa desaturase inhibition |
EP1799668A1 (en) | 2004-09-20 | 2007-06-27 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
US7919496B2 (en) | 2004-09-20 | 2011-04-05 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes |
AU2005329423A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
BRPI0515489A (en) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | heterocyclic derivatives and their use as stearoyl coat desaturase inhibitors |
JP5043668B2 (en) | 2004-09-20 | 2012-10-10 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | Heterocyclic derivatives and their use as therapeutic agents |
AR051092A1 (en) | 2004-09-20 | 2006-12-20 | Xenon Pharmaceuticals Inc | HETEROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF ESTEAROIL-COA |
US8101774B2 (en) | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
CN101208089A (en) | 2005-06-03 | 2008-06-25 | 泽农医药公司 | Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors |
TW200806292A (en) * | 2006-01-25 | 2008-02-01 | Synta Pharmaceuticals Corp | Vinyl-phenyl derivatives for inflammation and immune-related uses |
JP5028484B2 (en) * | 2006-06-28 | 2012-09-19 | グラクソ グループ リミテッド | Piperazinyl derivatives useful for the treatment of GPR38 receptor mediated diseases |
CL2008001671A1 (en) | 2007-06-08 | 2009-07-17 | Janssen Pharmaceutica Nv | Dgat1 inhibitor piperidine / piperazine derivative compounds, pharmaceutical composition comprising them; and its use in the treatment of metabolic diseases especially diabetes. |
JO2972B1 (en) * | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine/Piperazine derivatives |
US8835437B2 (en) | 2007-06-08 | 2014-09-16 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
CA2687918C (en) | 2007-06-08 | 2016-11-08 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
EP2296659B1 (en) | 2008-06-05 | 2016-12-21 | Janssen Pharmaceutica, N.V. | Drug combinations comprising a DGAT inhibitor and a PPAR-agonist |
NZ789295A (en) | 2009-04-29 | 2024-02-23 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
CN102458399B (en) | 2009-04-30 | 2014-04-23 | 美国中西部大学 | Novel therapeutic treatments using centhaquin |
CN104337809B (en) * | 2013-08-01 | 2018-08-14 | 中国医学科学院医药生物技术研究所 | The purposes of N- (4,5- dihydro -2- thiazoles) -2- (4- methylenedioxy phenoxies methyl) thiazole -4-carboxamide |
CA3188537A1 (en) * | 2020-08-06 | 2022-02-10 | Paul Sweetnam | Compositions and methods for treating metabolic dysregulation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5726711A (en) * | 1993-01-13 | 1998-03-10 | Hitachi America, Ltd. | Intra-coded video frame data processing methods and apparatus |
GB2276165A (en) * | 1993-03-17 | 1994-09-21 | Glaxo Group Ltd | Aniline and benzanilide compounds. |
FR2712591B1 (en) * | 1993-11-19 | 1996-02-09 | Pf Medicament | New arylpiperazines derived from indole, their preparation and their therapeutic use. |
GB9826412D0 (en) * | 1998-12-03 | 1999-01-27 | Glaxo Group Ltd | Chemical compounds |
GB0013346D0 (en) * | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Therapeutic benzamide derivatives |
-
2000
- 2000-06-01 GB GBGB0013378.5A patent/GB0013378D0/en not_active Ceased
-
2001
- 2001-06-01 EP EP01947331A patent/EP1286670A2/en not_active Withdrawn
- 2001-06-01 US US10/296,794 patent/US20040044008A1/en not_active Abandoned
- 2001-06-01 AU AU2001269046A patent/AU2001269046A1/en not_active Abandoned
- 2001-06-01 JP JP2002503294A patent/JP2003535900A/en active Pending
- 2001-06-01 WO PCT/EP2001/006242 patent/WO2001097810A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001097810A3 (en) | 2002-04-25 |
EP1286670A2 (en) | 2003-03-05 |
US20040044008A1 (en) | 2004-03-04 |
GB0013378D0 (en) | 2000-07-26 |
WO2001097810A2 (en) | 2001-12-27 |
JP2003535900A (en) | 2003-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001269046A1 (en) | Use of therapeutic benzamide derivatives | |
GB0013383D0 (en) | Therapeutic benzamide derivatives | |
AU2001252135A1 (en) | Therapeutic agents | |
AU2001294515A1 (en) | Use of stat-6 inhibitors as therapeutic agents | |
AU2001269314A1 (en) | Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds | |
GB0013346D0 (en) | Therapeutic benzamide derivatives | |
AU2002308891A1 (en) | Novel heterocyclic derivatives and medicinal use thereof | |
AU2001273903A1 (en) | Therapeutic agents | |
AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
AU2002358574A1 (en) | Therapeutic benzamide derivatives | |
AU7402201A (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
AU2002358076A1 (en) | Therapeutic benzamide derivatives | |
AU2001275696A1 (en) | Therapeutic agent | |
AU2001234180A1 (en) | Benzamide derivative and use thereof | |
AU2001264375A1 (en) | Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy | |
AU2001291233A1 (en) | Polymorphs of pioglitazone hydrochloride and their use as antidiabetics | |
GB0109287D0 (en) | Therapeutic benzamide derivatives | |
HK1053059A1 (en) | New use of imidazotriazinon derivatives | |
AU2002215923A1 (en) | Use of medicaments | |
HUP0600063A2 (en) | Novel therapeutic use of a thienylcyclohexylamine derivative | |
AU2001276556A1 (en) | Novel pharmaceutical use of quinnoline derivatives | |
AU2002221882A1 (en) | Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors | |
AU6106801A (en) | Trans-clitoral administration of therapy | |
IL150477A0 (en) | Novel therapeutic use of enoxaparin | |
AU3734901A (en) | Use of amidines |